Embryonic abnormalities at medical termination of pregnancy with mifepristone and misoprostol during first trimester: observational study.
Blanch
G
G
Department of Obstetrics and Gynaecology, University of Liverpool, Liverpool L69 3BX.
Quenby
S
S
Ballantyne
E S
ES
Gosden
C M
CM
Neilson
J P
JP
Holland
K
K
D000020:Abortifacient Agents, Nonsteroidal; D000021:Abortifacient Agents, Steroidal; D000028:Abortion, Induced / Q000379:methods*; D000284:Administration, Oral; D000293:Adolescent; D004338:Drug Combinations; D005260:Female; D005333:Fetus / Q000002:abnormalities*; D006801:Humans; D015735:Mifepristone; D016595:Misoprostol; D011247:Pregnancy; D011261:Pregnancy Trimester, First
D000020:Abortifacient Agents, Nonsteroidal; D000021:Abortifacient Agents, Steroidal; D004338:Drug Combinations; D016595:Misoprostol; D015735:Mifepristone